Kazue Johansen
Medical · Wailuku, HINPI 1487623369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 47.1% of the total. Reporting peaked in 2021 at $335 and has fallen 72.2% since, to $93 in 2025. That places this record below the midpoint for medical clinicians in HI, where the typical reported total is $521.
Across 23 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$240
- Amarin Pharma, Inc.$50
- Novo Nordisk$46
- GSK$43
- Pfizer$37
- Lilly USA, LLC$36
- plus $56 from 3 others
What the payments were for
- Food & beverage$509100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $240 |
| Amarin Pharma, Inc. | 1 | $50 |
| Novo Nordisk | 3 | $46 |
| GSK | 2 | $43 |
| Pfizer | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Merz North America, Inc. | 1 | $16 |
How this compares
$509 in reported general payments places this provider in the 45th percentile of 63 medical providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 22 | $240 |
| Metformin Hcl | 16 | $198 |
| Amlodipine Besylate | 16 | $150 |
| Losartan Potassium | 13 | $143 |
Paid to pharmacies, not to this prescriber.
Other medical in Wailuku
- Susan StewartWailuku$47K
- Leonard FergusonWailuku$422
- Elle FujimotoWailuku$146
- Lisa AdamsHonolulu$189K
- Leena HongHonolulu$30K
- Jeanelle AhunaHonolulu$16K
- Justin MaioHonolulu$12K
- Sarah BeatonKailua$10K
- Darren GeligaKailua Kona$8K
- Douglas WilliamsKailua$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.